Stefano Fais Selected Research

Lansoprazole (Prevacid)

8/2016	Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect.
7/2016	Proton pump inhibitors induce a caspase-independent antitumor effect against human multiple myeloma.
1/2016	Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells.
1/2015	Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma.
8/2014	High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.
12/2011	Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Fais Research Topics

Disease

80	Neoplasms (Cancer) 11/2022 - 10/2002
19	Melanoma (Melanoma, Malignant) 12/2020 - 10/2002
6	Breast Neoplasms (Breast Cancer) 12/2020 - 07/2009
5	Carcinogenesis 07/2021 - 12/2014
5	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 10/2017
5	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2009
5	Acidosis 01/2019 - 01/2014
4	Adenocarcinoma 12/2017 - 11/2003
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2020 - 12/2016
3	Disease Progression 01/2017 - 09/2009
2	Intestinal Neoplasms (Intestinal Cancer) 10/2020 - 12/2016
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 06/2005
2	Peptic Ulcer (Peptic Ulcers) 01/2017 - 11/2015
2	Carcinoma (Carcinomatosis) 05/2016 - 09/2015
2	Lymphoma (Lymphomas) 01/2015 - 11/2004
2	Osteosarcoma (Osteogenic Sarcoma) 10/2013 - 06/2012
1	Hypoxia (Hypoxemia) 04/2020
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2019
1	Hyperglycemia 01/2019
1	Glioma (Gliomas) 09/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Multiple Myeloma 07/2016
1	Infarction (Infarctions) 10/2015
1	Triple Negative Breast Neoplasms 08/2015

Drug/Important Bio-Agent (IBA)

26	Proton Pump InhibitorsIBA 11/2020 - 11/2004
11	Protons (Proton)IBA 10/2020 - 06/2010
9	Pharmaceutical PreparationsIBA 07/2020 - 11/2003
9	Proteins (Proteins, Gene)FDA Link 12/2018 - 11/2007
9	Proton Pumps (Proton Pump)IBA 01/2017 - 06/2007
6	Biomarkers (Surrogate Marker)IBA 04/2021 - 10/2013
6	Lactic Acid (Lactate)FDA LinkGeneric 04/2020 - 12/2005
6	Adenosine Triphosphatases (ATPase)IBA 01/2020 - 06/2007
6	Lansoprazole (Prevacid)FDA LinkGeneric 08/2016 - 12/2011
6	ezrinIBA 01/2015 - 11/2003
5	Tumor Biomarkers (Tumor Markers)IBA 09/2020 - 01/2014
5	AcidsIBA 07/2020 - 11/2004
5	Glucose (Dextrose)FDA LinkGeneric 07/2020 - 05/2010
4	LipidsIBA 12/2020 - 12/2009
4	Biological ProductsIBA 01/2019 - 04/2006
4	CaspasesIBA 07/2016 - 06/2005
4	Antineoplastic Agents (Antineoplastics)IBA 11/2013 - 11/2004
4	AntigensIBA 12/2009 - 10/2002
3	Prostate-Specific Antigen (Semenogelase)IBA 04/2021 - 10/2017
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2020 - 01/2012
3	Carbonic Anhydrase IXIBA 12/2020 - 01/2016
3	Rabeprazole (Aciphex)FDA Link 10/2020 - 12/2016
3	Oxygen (Dioxygen)IBA 07/2020 - 01/2012
3	BuffersIBA 01/2019 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 11/2004
2	Protein Isoforms (Isoforms)IBA 12/2020 - 11/2013
2	Capecitabine (Xeloda)FDA Link 10/2020 - 12/2016
2	EnzymesIBA 07/2020 - 01/2012
2	Amino Acids FDA Link 07/2020 - 06/2012
2	Nucleic AcidsIBA 07/2020 - 12/2018
2	AntioxidantsIBA 04/2020 - 01/2019
2	MicroRNAs (MicroRNA)IBA 09/2018 - 09/2013
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 12/2017 - 10/2015
2	Acridine OrangeIBA 12/2017 - 01/2012
2	Chaperonin 60IBA 01/2017 - 09/2015
2	SugarsIBA 01/2017 - 11/2015
2	Omeprazole (Prilosec)FDA LinkGeneric 07/2016 - 11/2004
2	ChaperoninsIBA 05/2016 - 09/2015
2	moesinIBA 01/2015 - 06/2012
2	radixinIBA 01/2015 - 06/2012
2	Esomeprazole (Nexium)FDA Link 10/2013 - 11/2004
2	Caveolin 1IBA 12/2009 - 01/2009
2	Small Interfering RNA (siRNA)IBA 07/2009 - 11/2007
2	Proton-Translocating ATPases (ATPase, H+)IBA 06/2007 - 12/2005
2	Cytotoxins (Cytolysins)IBA 06/2005 - 11/2004
2	MART-1 AntigenIBA 02/2003 - 10/2002
1	DNA (Deoxyribonucleic Acid)IBA 07/2021
1	Membrane LipidsIBA 12/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2020
1	NADP (NADPH)IBA 07/2020
1	ElectrolytesIBA 04/2020
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	APTIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Indicators and Reagents (Reagents)IBA 12/2018
1	Molecular Chaperones (Chaperone, Molecular)IBA 09/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2016
1	Generic DrugsIBA 08/2016
1	Histone Deacetylase InhibitorsIBA 05/2016
1	Vorinostat FDA Link 05/2016
1	ClusterinIBA 10/2015
1	Ion Channels (Ion Channel)IBA 10/2015
1	thiamine triphosphorate (TTP)IBA 08/2015
1	Prion ProteinsIBA 07/2015

Therapy/Procedure

25	Therapeutics 11/2022 - 06/2005
15	Drug Therapy (Chemotherapy) 10/2020 - 07/2009
3	Oral Administration 01/2019 - 01/2016
3	Immunotherapy 01/2013 - 02/2003
2	Precision Medicine 12/2017 - 09/2015
2	Photochemotherapy (Photodynamic Therapy) 12/2017 - 01/2012
1	Sublingual Administration 01/2019
1	Operative Surgical Procedures 10/2017
1	Salvage Therapy 12/2016